| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.07e-07 | 26 | 91 | 5 | GO:0005248 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 1.07e-07 | 26 | 91 | 5 | GO:0031420 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.30e-07 | 52 | 91 | 6 | GO:0005272 | |
| GeneOntologyMolecularFunction | sodium ion binding | 3.90e-07 | 14 | 91 | 4 | GO:0031402 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DHX16 ATP8B3 HSP90B2P DNAH10 DHX38 ATP2C2 MLH1 KIF13A DNAH5 DNAH8 DDX3X ABCB4 | 7.56e-07 | 441 | 91 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DHX16 ATP8B3 HSP90B2P DNAH10 ZGRF1 DHX38 ATP2C2 MLH1 KIF13A DNAH5 DNAH8 DDX3X ABCB4 | 4.11e-06 | 614 | 91 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.32e-05 | 171 | 91 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | ATP-dependent diacylglycerol kinase activity | 1.47e-05 | 11 | 91 | 3 | GO:0004143 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.66e-05 | 118 | 91 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.67e-05 | 343 | 91 | 9 | GO:0005261 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DHX16 ATP8B3 HSP90B2P DNAH10 DHX38 ATP2C2 ENTPD5 MLH1 KIF13A DNAH5 DNAH8 DDX3X ABCB4 | 4.81e-05 | 775 | 91 | 13 | GO:0017111 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC38A1 KCNF1 SCN1A SCN2A SCN4A ATP2C2 SCN8A SCN9A GRIN2C CNGB1 | 5.08e-05 | 465 | 91 | 10 | GO:0046873 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 7.11e-05 | 18 | 91 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DHX16 ATP8B3 HSP90B2P DNAH10 DHX38 ATP2C2 ENTPD5 MLH1 KIF13A DNAH5 DNAH8 DDX3X ABCB4 | 1.07e-04 | 839 | 91 | 13 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DHX16 ATP8B3 HSP90B2P DNAH10 DHX38 ATP2C2 ENTPD5 MLH1 KIF13A DNAH5 DNAH8 DDX3X ABCB4 | 1.09e-04 | 840 | 91 | 13 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DHX16 ATP8B3 HSP90B2P DNAH10 DHX38 ATP2C2 ENTPD5 MLH1 KIF13A DNAH5 DNAH8 DDX3X ABCB4 | 1.09e-04 | 840 | 91 | 13 | GO:0016818 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC38A1 KCNF1 SCN1A SCN2A SCN4A CNGB3 ATP2C2 SCN8A SCN9A GRIN2C CNGB1 | 2.14e-04 | 664 | 91 | 11 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.45e-04 | 459 | 91 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.76e-04 | 28 | 91 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.94e-04 | 70 | 91 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | intracellularly cGMP-activated cation channel activity | 4.25e-04 | 7 | 91 | 2 | GO:0005223 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC38A1 KCNF1 SCN1A SCN2A SCN4A ATP2C2 SCN8A SCN9A GRIN2C CNGB1 | 5.67e-04 | 627 | 91 | 10 | GO:0022890 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 6.36e-04 | 37 | 91 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | channel activity | 6.50e-04 | 525 | 91 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 6.58e-04 | 526 | 91 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | transporter activity | SLC38A1 ATP8B3 IGF1R KCNF1 SCN1A SCN2A SCN4A CNGB3 ATP2C2 SCN8A SCN9A GRIN2C CNGB1 ABCB4 CFHR4 | 6.87e-04 | 1289 | 91 | 15 | GO:0005215 |
| GeneOntologyMolecularFunction | lipid kinase activity | 8.61e-04 | 41 | 91 | 3 | GO:0001727 | |
| GeneOntologyMolecularFunction | intracellularly cAMP-activated cation channel activity | 9.03e-04 | 10 | 91 | 2 | GO:0005222 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC38A1 KCNF1 SCN1A SCN2A SCN4A CNGB3 ATP2C2 SCN8A SCN9A GRIN2C CNGB1 | 9.47e-04 | 793 | 91 | 11 | GO:0015075 |
| GeneOntologyMolecularFunction | complement component C3b binding | 1.32e-03 | 12 | 91 | 2 | GO:0001851 | |
| GeneOntologyMolecularFunction | intracellularly cyclic nucleotide-activated monoatomic cation channel activity | 1.55e-03 | 13 | 91 | 2 | GO:0005221 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-activated monoatomic ion channel activity | 1.55e-03 | 13 | 91 | 2 | GO:0043855 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC38A1 KCNF1 SCN1A SCN2A SCN4A ATP2C2 SCN8A SCN9A GRIN2C CNGB1 | 2.35e-03 | 758 | 91 | 10 | GO:0015318 |
| GeneOntologyMolecularFunction | cGMP binding | 2.36e-03 | 16 | 91 | 2 | GO:0030553 | |
| GeneOntologyMolecularFunction | floppase activity | 2.36e-03 | 16 | 91 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 2.67e-03 | 17 | 91 | 2 | GO:0099508 | |
| GeneOntologyMolecularFunction | lamin binding | 3.34e-03 | 19 | 91 | 2 | GO:0005521 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 3.70e-03 | 20 | 91 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | gated channel activity | 4.24e-03 | 334 | 91 | 6 | GO:0022836 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 4.79e-07 | 36 | 90 | 5 | GO:0086010 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 2.22e-06 | 87 | 90 | 6 | GO:0086001 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 3.57e-06 | 208 | 90 | 8 | GO:0035725 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 7.52e-06 | 62 | 90 | 5 | GO:0086002 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 8.14e-06 | 63 | 90 | 5 | GO:0019228 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 8.55e-06 | 167 | 90 | 7 | GO:0060048 | |
| GeneOntologyBiologicalProcess | prophase | 9.43e-06 | 10 | 90 | 3 | GO:0051324 | |
| GeneOntologyBiologicalProcess | meiotic prophase I | 9.43e-06 | 10 | 90 | 3 | GO:0007128 | |
| GeneOntologyBiologicalProcess | lipid phosphorylation | 1.29e-05 | 11 | 90 | 3 | GO:0046834 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 1.50e-05 | 121 | 90 | 6 | GO:0051899 | |
| GeneOntologyBiologicalProcess | meiosis I cell cycle phase | 1.72e-05 | 12 | 90 | 3 | GO:0098764 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 2.72e-05 | 275 | 90 | 8 | GO:0006814 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle phase | 2.82e-05 | 14 | 90 | 3 | GO:0098762 | |
| GeneOntologyBiologicalProcess | M phase | 2.82e-05 | 14 | 90 | 3 | GO:0000279 | |
| GeneOntologyBiologicalProcess | action potential | 2.84e-05 | 201 | 90 | 7 | GO:0001508 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | KCNF1 SYNE1 SCN1A SCN2A SCN4A SCN8A SCN9A MTMR2 GRIN2C DMD CNGB1 | 3.15e-05 | 559 | 90 | 11 | GO:0042391 |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 3.75e-05 | 210 | 90 | 7 | GO:0060294 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 4.35e-05 | 215 | 90 | 7 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 4.35e-05 | 215 | 90 | 7 | GO:0001539 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 4.62e-05 | 217 | 90 | 7 | GO:0006941 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 5.43e-05 | 93 | 90 | 5 | GO:0086003 | |
| GeneOntologyBiologicalProcess | neuromuscular process | 5.81e-05 | 225 | 90 | 7 | GO:0050905 | |
| GeneOntologyBiologicalProcess | determination of adult lifespan | 9.07e-05 | 54 | 90 | 4 | GO:0008340 | |
| GeneOntologyBiologicalProcess | pachytene | 1.12e-04 | 4 | 90 | 2 | GO:0000239 | |
| GeneOntologyBiologicalProcess | nerve development | 1.16e-04 | 109 | 90 | 5 | GO:0021675 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 1.31e-04 | 112 | 90 | 5 | GO:0019226 | |
| GeneOntologyBiologicalProcess | cilium movement | 1.46e-04 | 261 | 90 | 7 | GO:0003341 | |
| GeneOntologyBiologicalProcess | outer dynein arm assembly | 1.52e-04 | 24 | 90 | 3 | GO:0036158 | |
| GeneOntologyBiologicalProcess | negative regulation of protein kinase C signaling | 1.87e-04 | 5 | 90 | 2 | GO:0090038 | |
| GeneOntologyBiologicalProcess | cell cycle phase | 2.18e-04 | 27 | 90 | 3 | GO:0022403 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 2.37e-04 | 127 | 90 | 5 | GO:0070252 | |
| GeneOntologyBiologicalProcess | diacylglycerol metabolic process | 2.43e-04 | 28 | 90 | 3 | GO:0046339 | |
| GeneOntologyBiologicalProcess | heart contraction | 3.29e-04 | 298 | 90 | 7 | GO:0060047 | |
| GeneOntologyBiologicalProcess | heart process | 4.09e-04 | 309 | 90 | 7 | GO:0003015 | |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 4.36e-04 | 145 | 90 | 5 | GO:0001578 | |
| GeneOntologyBiologicalProcess | phosphatidic acid biosynthetic process | 5.17e-04 | 36 | 90 | 3 | GO:0006654 | |
| GeneOntologyBiologicalProcess | olfactory nerve development | 5.18e-04 | 8 | 90 | 2 | GO:0021553 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 5.57e-04 | 153 | 90 | 5 | GO:0030048 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 6.15e-04 | 238 | 90 | 6 | GO:0050954 | |
| GeneOntologyBiologicalProcess | phosphatidic acid metabolic process | 7.60e-04 | 41 | 90 | 3 | GO:0046473 | |
| GeneOntologyBiologicalProcess | axonemal dynein complex assembly | 7.60e-04 | 41 | 90 | 3 | GO:0070286 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC38A1 KCNF1 SCN1A SCN2A SCN4A CNGB3 ATP2C2 SCN8A SCN9A GRIN2C DMD CNGB1 | 7.90e-04 | 942 | 90 | 12 | GO:0098655 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 8.31e-09 | 17 | 91 | 5 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.53e-07 | 29 | 91 | 5 | GO:0034706 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 3.96e-06 | 25 | 91 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 5.81e-06 | 378 | 91 | 10 | GO:0034702 | |
| GeneOntologyCellularComponent | cation channel complex | 8.63e-06 | 235 | 91 | 8 | GO:0034703 | |
| GeneOntologyCellularComponent | outer dynein arm | 1.71e-05 | 12 | 91 | 3 | GO:0036157 | |
| GeneOntologyCellularComponent | transporter complex | CYBB ATP8B3 KCNF1 SCN1A SCN2A SCN4A CNGB3 SCN8A SCN9A GRIN2C CNGB1 | 2.67e-05 | 550 | 91 | 11 | GO:1990351 |
| GeneOntologyCellularComponent | axon | SLC38A1 IGF1R IMPA1 SCN1A SCN2A ROR1 SCN4A SCN8A SCN9A MTMR2 TSC2 DMD CNGB1 CFHR4 | 2.97e-05 | 891 | 91 | 14 | GO:0030424 |
| GeneOntologyCellularComponent | node of Ranvier | 8.62e-05 | 20 | 91 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | dynein complex | 9.00e-05 | 54 | 91 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 9.23e-05 | 523 | 91 | 10 | GO:1902495 | |
| GeneOntologyCellularComponent | axon initial segment | 2.69e-04 | 29 | 91 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | intracellular cyclic nucleotide activated cation channel complex | 3.88e-04 | 7 | 91 | 2 | GO:0017071 | |
| GeneOntologyCellularComponent | microtubule associated complex | 6.95e-04 | 161 | 91 | 5 | GO:0005875 | |
| GeneOntologyCellularComponent | synaptic membrane | 9.87e-04 | 583 | 91 | 9 | GO:0097060 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 2.18e-03 | 785 | 91 | 10 | GO:0098797 | |
| HumanPheno | Complex febrile seizure | 4.50e-06 | 16 | 38 | 4 | HP:0011172 | |
| HumanPheno | Photosensitive myoclonic seizure | 2.09e-05 | 8 | 38 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 2.09e-05 | 8 | 38 | 3 | HP:0200048 | |
| HumanPheno | Focal hemiclonic seizure | 2.98e-05 | 25 | 38 | 4 | HP:0006813 | |
| HumanPheno | Cortical dysplasia | 5.10e-05 | 56 | 38 | 5 | HP:0002539 | |
| HumanPheno | Limited neck range of motion | 6.07e-05 | 11 | 38 | 3 | HP:0000466 | |
| HumanPheno | Epilepsia partialis continua | 8.05e-05 | 12 | 38 | 3 | HP:0012847 | |
| HumanPheno | Focal automatism seizure | 8.05e-05 | 12 | 38 | 3 | HP:0032898 | |
| HumanPheno | Obsessive-compulsive trait | 9.23e-05 | 33 | 38 | 4 | HP:0008770 | |
| HumanPheno | Generalized clonic seizure | 1.04e-04 | 34 | 38 | 4 | HP:0011169 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 1.04e-04 | 13 | 38 | 3 | HP:0007058 | |
| HumanPheno | Facial tics | 1.64e-04 | 15 | 38 | 3 | HP:0011468 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 1.64e-04 | 15 | 38 | 3 | HP:0007207 | |
| HumanPheno | Dysgenesis of the hippocampus | 2.01e-04 | 16 | 38 | 3 | HP:0025101 | |
| HumanPheno | Focal clonic seizure | 2.41e-04 | 42 | 38 | 4 | HP:0002266 | |
| HumanPheno | Focal motor status epilepticus | 2.42e-04 | 17 | 38 | 3 | HP:0032663 | |
| HumanPheno | Atypical absence status epilepticus | 2.42e-04 | 17 | 38 | 3 | HP:0011151 | |
| HumanPheno | Visually-induced seizure | 2.89e-04 | 18 | 38 | 3 | HP:0020216 | |
| HumanPheno | Generalized non-convulsive status epilepticus without coma | 2.89e-04 | 18 | 38 | 3 | HP:0032860 | |
| HumanPheno | Focal impaired awareness seizure | 2.93e-04 | 126 | 38 | 6 | HP:0002384 | |
| HumanPheno | Clonic seizure | 2.99e-04 | 81 | 38 | 5 | HP:0020221 | |
| HumanPheno | Atypical absence seizure | 3.43e-04 | 46 | 38 | 4 | HP:0007270 | |
| HumanPheno | Non-convulsive status epilepticus without coma | 4.00e-04 | 20 | 38 | 3 | HP:0032671 | |
| HumanPheno | Abnormal hippocampus morphology | 4.05e-04 | 48 | 38 | 4 | HP:0025100 | |
| HumanPheno | Abnormal morphology of the limbic system | 4.39e-04 | 49 | 38 | 4 | HP:0007343 | |
| HumanPheno | EEG with spike-wave complexes | 4.40e-04 | 88 | 38 | 5 | HP:0010850 | |
| HumanPheno | Talipes valgus | 4.64e-04 | 21 | 38 | 3 | HP:0004684 | |
| HumanPheno | Neonatal electro-clinical non-motor seizure | 5.34e-04 | 5 | 38 | 2 | HP:0032812 | |
| HumanPheno | Neonatal seizure with electrographic correlate | 5.34e-04 | 5 | 38 | 2 | HP:0032808 | |
| HumanPheno | Neonatal electro-clinical seizure | 5.34e-04 | 5 | 38 | 2 | HP:0032809 | |
| HumanPheno | Neonatal electro-clinical seizure with behavior arrest | 5.34e-04 | 5 | 38 | 2 | HP:0032823 | |
| HumanPheno | Focal head nodding automatism seizure | 5.34e-04 | 5 | 38 | 2 | HP:0032906 | |
| HumanPheno | Reflex seizure | 5.35e-04 | 22 | 38 | 3 | HP:0020207 | |
| HumanPheno | Bilateral tonic-clonic seizure with generalized onset | 5.52e-04 | 52 | 38 | 4 | HP:0025190 | |
| HumanPheno | Myoclonic seizure | 5.59e-04 | 262 | 38 | 8 | HP:0032794 | |
| HumanPheno | Tibial torsion | 6.12e-04 | 23 | 38 | 3 | HP:0100694 | |
| HumanPheno | Epileptic spasm | 7.12e-04 | 207 | 38 | 7 | HP:0011097 | |
| HumanPheno | Pes valgus | 7.33e-04 | 56 | 38 | 4 | HP:0008081 | |
| HumanPheno | Normal interictal EEG | 7.98e-04 | 6 | 38 | 2 | HP:0002372 | |
| MousePheno | increased circulating LDL cholesterol level | 2.68e-07 | 80 | 77 | 7 | MP:0000182 | |
| MousePheno | impaired muscle relaxation | 1.58e-05 | 28 | 77 | 4 | MP:0003157 | |
| MousePheno | abnormal circulating LDL cholesterol level | 3.12e-05 | 163 | 77 | 7 | MP:0000181 | |
| MousePheno | abnormal circulating non-HDL cholesterol level | 5.88e-05 | 180 | 77 | 7 | MP:0020151 | |
| Domain | INT_SG_DDX_CT_C | 1.15e-10 | 8 | 88 | 5 | PF15300 | |
| Domain | INT_SG_DDX_CT_C | 1.15e-10 | 8 | 88 | 5 | IPR029307 | |
| Domain | Na_channel_asu | 5.12e-10 | 10 | 88 | 5 | IPR001696 | |
| Domain | Na_trans_assoc | 5.12e-10 | 10 | 88 | 5 | IPR010526 | |
| Domain | Na_trans_assoc | 5.12e-10 | 10 | 88 | 5 | PF06512 | |
| Domain | Na_trans_cytopl | 6.85e-09 | 6 | 88 | 4 | PF11933 | |
| Domain | Na_trans_cytopl | 6.85e-09 | 6 | 88 | 4 | IPR024583 | |
| Domain | Ion_trans_dom | 6.44e-08 | 114 | 88 | 8 | IPR005821 | |
| Domain | Ion_trans | 6.44e-08 | 114 | 88 | 8 | PF00520 | |
| Domain | Channel_four-helix_dom | 2.75e-07 | 57 | 88 | 6 | IPR027359 | |
| Domain | - | 2.75e-07 | 57 | 88 | 6 | 1.20.120.350 | |
| Domain | IQ | 2.25e-06 | 81 | 88 | 6 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 4.17e-06 | 90 | 88 | 6 | IPR000048 | |
| Domain | IQ | 5.05e-06 | 93 | 88 | 6 | PS50096 | |
| Domain | DHC_N1 | 5.56e-06 | 8 | 88 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 5.56e-06 | 8 | 88 | 3 | IPR013594 | |
| Domain | EF-hand-dom_pair | 8.33e-06 | 287 | 88 | 9 | IPR011992 | |
| Domain | DAGK_acc | 1.18e-05 | 10 | 88 | 3 | PF00609 | |
| Domain | Diacylglycerol_kin_accessory | 1.18e-05 | 10 | 88 | 3 | IPR000756 | |
| Domain | DAGKa | 1.18e-05 | 10 | 88 | 3 | SM00045 | |
| Domain | IQ | 2.11e-05 | 71 | 88 | 5 | PF00612 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.54e-05 | 14 | 88 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.54e-05 | 14 | 88 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.54e-05 | 14 | 88 | 3 | IPR013602 | |
| Domain | DHC_N2 | 3.54e-05 | 14 | 88 | 3 | PF08393 | |
| Domain | MT | 3.54e-05 | 14 | 88 | 3 | PF12777 | |
| Domain | AAA_8 | 3.54e-05 | 14 | 88 | 3 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 3.54e-05 | 14 | 88 | 3 | IPR011704 | |
| Domain | DAGKc | 3.54e-05 | 14 | 88 | 3 | SM00046 | |
| Domain | AAA_5 | 3.54e-05 | 14 | 88 | 3 | PF07728 | |
| Domain | DHC_fam | 4.41e-05 | 15 | 88 | 3 | IPR026983 | |
| Domain | Diacylglycerol_kinase_cat_dom | 4.41e-05 | 15 | 88 | 3 | IPR001206 | |
| Domain | DAGK_cat | 4.41e-05 | 15 | 88 | 3 | PF00781 | |
| Domain | DAGK | 4.41e-05 | 15 | 88 | 3 | PS50146 | |
| Domain | Dynein_heavy_dom | 4.41e-05 | 15 | 88 | 3 | IPR004273 | |
| Domain | Dynein_heavy | 4.41e-05 | 15 | 88 | 3 | PF03028 | |
| Domain | RmlC_Cupin | 5.41e-05 | 16 | 88 | 3 | IPR011051 | |
| Domain | NAD/diacylglycerol_kinase | 6.55e-05 | 17 | 88 | 3 | IPR016064 | |
| Domain | DAG_kinase_N | 6.56e-05 | 3 | 88 | 2 | PF14513 | |
| Domain | DAG_kinase_typeI_N | 6.56e-05 | 3 | 88 | 2 | IPR029477 | |
| Domain | - | 6.56e-05 | 3 | 88 | 2 | 1.10.238.110 | |
| Domain | - | 1.46e-03 | 261 | 88 | 6 | 1.10.238.10 | |
| Domain | C1_1 | 2.46e-03 | 57 | 88 | 3 | PF00130 | |
| Domain | Post-SET_dom | 2.52e-03 | 16 | 88 | 2 | IPR003616 | |
| Domain | PostSET | 2.52e-03 | 16 | 88 | 2 | SM00508 | |
| Domain | cNMP-bd_CS | 2.52e-03 | 16 | 88 | 2 | IPR018488 | |
| Domain | POST_SET | 2.52e-03 | 16 | 88 | 2 | PS50868 | |
| Domain | DUF1605 | 2.85e-03 | 17 | 88 | 2 | IPR011709 | |
| Domain | OB_NTP_bind | 2.85e-03 | 17 | 88 | 2 | PF07717 | |
| Domain | HA2 | 3.20e-03 | 18 | 88 | 2 | SM00847 | |
| Domain | HA2 | 3.20e-03 | 18 | 88 | 2 | PF04408 | |
| Domain | Furin_repeat | 3.20e-03 | 18 | 88 | 2 | IPR006212 | |
| Domain | Helicase-assoc_dom | 3.20e-03 | 18 | 88 | 2 | IPR007502 | |
| Domain | HATPase_c | 3.20e-03 | 18 | 88 | 2 | SM00387 | |
| Domain | FU | 3.20e-03 | 18 | 88 | 2 | SM00261 | |
| Domain | ZF_DAG_PE_1 | 3.42e-03 | 64 | 88 | 3 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 3.42e-03 | 64 | 88 | 3 | PS50081 | |
| Domain | HATPase_c | 3.56e-03 | 19 | 88 | 2 | PF02518 | |
| Domain | C1 | 3.58e-03 | 65 | 88 | 3 | SM00109 | |
| Domain | PE/DAG-bd | 3.73e-03 | 66 | 88 | 3 | IPR002219 | |
| Domain | - | 3.95e-03 | 20 | 88 | 2 | 3.30.565.10 | |
| Domain | HATPase_C | 4.35e-03 | 21 | 88 | 2 | IPR003594 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 3.22e-07 | 31 | 67 | 5 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 3.80e-07 | 32 | 67 | 5 | M27455 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 7.53e-06 | 27 | 67 | 4 | M47755 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 4.85e-05 | 203 | 67 | 7 | M5485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 5.00e-05 | 43 | 67 | 4 | M47669 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 5.62e-05 | 367 | 67 | 9 | M48346 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 6.00e-05 | 45 | 67 | 4 | M47670 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 2.19e-04 | 25 | 67 | 3 | MM14511 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 2.71e-04 | 121 | 67 | 5 | M872 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 2.77e-04 | 27 | 67 | 3 | M12123 | |
| Pathway | WP_DRAVET_SYNDROME | 3.09e-04 | 28 | 67 | 3 | M45519 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR | 3.30e-04 | 6 | 67 | 2 | M47880 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 3.77e-04 | 130 | 67 | 5 | M27454 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 4.62e-04 | 76 | 67 | 4 | M9052 | |
| Pubmed | Identification of cancer/testis-antigen genes by massively parallel signature sequencing. | CT45A8 CT45A6 CT45A1 CT45A3 CT45A10 CT45A5 CT45A2 CT45A7 CT45A9 | 2.32e-20 | 15 | 93 | 9 | 15905330 |
| Pubmed | 1.53e-11 | 9 | 93 | 5 | 16382098 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 7.16e-10 | 6 | 93 | 4 | 23652591 | |
| Pubmed | 5.97e-09 | 9 | 93 | 4 | 15746173 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 32845893 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 28518218 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 17928448 | ||
| Pubmed | CYBB PLA2R1 CT45A6 CT45A1 TMEM132D CT45A3 CT45A10 SCN2A KCTD14 CT45A2 CT45A7 DDX3X CT45A9 | 3.04e-08 | 674 | 93 | 13 | 37196079 | |
| Pubmed | 3.36e-08 | 13 | 93 | 4 | 15123669 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 17537961 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 35031483 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 29578003 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 21156207 | ||
| Pubmed | 1.84e-07 | 5 | 93 | 3 | 8812438 | ||
| Pubmed | 1.84e-07 | 5 | 93 | 3 | 17724025 | ||
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 6.43e-07 | 7 | 93 | 3 | 25818041 | |
| Pubmed | 1.03e-06 | 8 | 93 | 3 | 9412493 | ||
| Pubmed | 3.01e-06 | 11 | 93 | 3 | 17021016 | ||
| Pubmed | 3.31e-06 | 234 | 93 | 7 | 36243803 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 4.00e-06 | 12 | 93 | 3 | 30175250 | |
| Pubmed | 6.60e-06 | 14 | 93 | 3 | 9373155 | ||
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 7.07e-06 | 2 | 93 | 2 | 37901435 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 18079277 | ||
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 7.07e-06 | 2 | 93 | 2 | 26410685 | |
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 7.07e-06 | 2 | 93 | 2 | 10827969 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 19694741 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 35348308 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 15760941 | ||
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 7.07e-06 | 2 | 93 | 2 | 1317301 | |
| Pubmed | Voltage-gated sodium channel (SkM1) content in dystrophin-deficient muscle. | 7.07e-06 | 2 | 93 | 2 | 11316257 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 31439038 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 21903813 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 31943325 | ||
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 7.07e-06 | 2 | 93 | 2 | 15249644 | |
| Pubmed | Sodium channel slow inactivation interferes with open channel block. | 7.07e-06 | 2 | 93 | 2 | 27174182 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 18601978 | ||
| Pubmed | FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. | 7.07e-06 | 2 | 93 | 2 | 19465131 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 17515466 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 30693367 | ||
| Pubmed | Block of a subset of sodium channels exacerbates experimental autoimmune encephalomyelitis. | 7.07e-06 | 2 | 93 | 2 | 23735284 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 29649454 | ||
| Pubmed | Primary ciliary dyskinesia: improving the diagnostic approach. | 7.07e-06 | 2 | 93 | 2 | 19300264 | |
| Pubmed | IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas. | 7.07e-06 | 2 | 93 | 2 | 26173023 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 33096315 | ||
| Pubmed | Sodium channel expression within chronic multiple sclerosis plaques. | 7.07e-06 | 2 | 93 | 2 | 17805013 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 26311622 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 33411788 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 21377452 | ||
| Pubmed | Persistent Nav1.1 and Nav1.6 currents drive spinal locomotor functions through nonlinear dynamics. | 7.07e-06 | 2 | 93 | 2 | 37665666 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 17881658 | ||
| Pubmed | 1.15e-05 | 187 | 93 | 6 | 26460568 | ||
| Pubmed | Regulation of alternative splicing by SRrp86 and its interacting proteins. | 1.70e-05 | 57 | 93 | 4 | 14559993 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 19284629 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 32185219 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 32005694 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 10622723 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 33895391 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 23859570 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 11379879 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 16033895 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 26893377 | ||
| Pubmed | DNAH6 and Its Interactions with PCD Genes in Heterotaxy and Primary Ciliary Dyskinesia. | 2.12e-05 | 3 | 93 | 2 | 26918822 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 21637784 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 38514708 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 26182346 | ||
| Pubmed | De novo SCN1A, SCN8A, and CLCN2 mutations in childhood absence epilepsy. | 2.12e-05 | 3 | 93 | 2 | 31054517 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 28784306 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 12610651 | ||
| Pubmed | GRP94 is an IGF-1R chaperone and regulates beta cell death in diabetes. | 2.12e-05 | 3 | 93 | 2 | 38811543 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 18784617 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 17544618 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 15750039 | ||
| Pubmed | Mammalian diacylglycerol kinases, a family of lipid kinases with signaling functions. | 2.12e-05 | 3 | 93 | 2 | 10206945 | |
| Pubmed | Role of sodium channel subtype in action potential generation by neocortical pyramidal neurons. | 2.12e-05 | 3 | 93 | 2 | 29991598 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 20038812 | ||
| Pubmed | Role of the hippocampus in Nav1.6 (Scn8a) mediated seizure resistance. | 2.12e-05 | 3 | 93 | 2 | 24704313 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 19270815 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 25155934 | ||
| Pubmed | The sorting receptor Rer1 controls Purkinje cell function via voltage gated sodium channels. | 2.12e-05 | 3 | 93 | 2 | 28117367 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 17135300 | ||
| Pubmed | Two factor H-related proteins from the mouse: expression analysis and functional characterization. | 2.12e-05 | 3 | 93 | 2 | 17028856 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 25684976 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 14973256 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 15302875 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 3.72e-05 | 139 | 93 | 5 | 16985003 | |
| Pubmed | Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms. | 4.23e-05 | 4 | 93 | 2 | 26637798 | |
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 17367211 | ||
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 18440230 | ||
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 22260870 | ||
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 28939216 | ||
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 36793547 | ||
| Pubmed | Mutations in dynein genes in patients affected by isolated non-syndromic asthenozoospermia. | 4.23e-05 | 4 | 93 | 2 | 18492703 | |
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 15634774 | ||
| Pubmed | Models for discovery of targeted therapy in genetic epileptic encephalopathies. | 4.23e-05 | 4 | 93 | 2 | 28742937 | |
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 35801810 | ||
| Pubmed | DNAI2 mutations cause primary ciliary dyskinesia with defects in the outer dynein arm. | 4.23e-05 | 4 | 93 | 2 | 18950741 | |
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 35385735 | ||
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 24164424 | ||
| Pubmed | Localization of dystrophin gene transcripts during mouse embryogenesis. | 4.23e-05 | 4 | 93 | 2 | 1429837 | |
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 4.23e-05 | 4 | 93 | 2 | 8974318 | |
| Interaction | SCN4B interactions | 5.07e-06 | 8 | 92 | 3 | int:SCN4B | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq26 | CT45A8 CT45A6 CT45A1 CT45A3 CT45A10 CT45A5 CT45A2 CT45A7 CT45A9 | 8.21e-11 | 171 | 93 | 9 | chrXq26 |
| Cytoband | Xq26.3 | 2.68e-07 | 67 | 93 | 5 | Xq26.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 1.35e-04 | 127 | 93 | 4 | chr2q24 | |
| Cytoband | 2q24.3 | 4.78e-04 | 16 | 93 | 2 | 2q24.3 | |
| Cytoband | 12q24.31 | 5.91e-04 | 80 | 93 | 3 | 12q24.31 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 5.91e-11 | 9 | 64 | 5 | 1203 | |
| GeneFamily | Dyneins, axonemal | 3.28e-07 | 17 | 64 | 4 | 536 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 4.99e-06 | 10 | 64 | 3 | 1178 | |
| GeneFamily | Cyclic nucleotide gated channels | 5.45e-04 | 10 | 64 | 2 | 250 | |
| GeneFamily | DEAH-box helicases | 1.43e-03 | 16 | 64 | 2 | 500 | |
| GeneFamily | PHD finger proteins | 3.99e-03 | 90 | 64 | 3 | 88 | |
| GeneFamily | Phosphoinositide phosphatases | 5.71e-03 | 32 | 64 | 2 | 1079 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 6.43e-03 | 34 | 64 | 2 | 487 | |
| GeneFamily | Complement system|Sushi domain containing | 7.19e-03 | 36 | 64 | 2 | 492 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_1_CELL | CT45A8 CT45A6 CT45A1 CT45A3 CT45A10 CT45A5 CT45A2 CT45A7 CT45A9 | 2.85e-12 | 69 | 93 | 9 | M45681 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL | CT45A8 CT45A6 CT45A1 CT45A3 CT45A10 CT45A5 CT45A2 CT45A7 CT45A9 | 1.25e-10 | 104 | 93 | 9 | M45682 |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_DN | 2.16e-05 | 158 | 93 | 6 | M372 | |
| Coexpression | GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS | 3.75e-05 | 459 | 93 | 9 | M39136 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 6.78e-09 | 193 | 92 | 8 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.62e-09 | 199 | 92 | 8 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.76e-08 | 157 | 92 | 7 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.39e-07 | 190 | 92 | 7 | d24af6af3271e34afab744352afd28be8a7cc5c3 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.39e-07 | 190 | 92 | 7 | 71a00f63fdd4eb4cc6f190d37e7a0417cdaafacb | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.54e-07 | 193 | 92 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.54e-07 | 193 | 92 | 7 | 2f203f6f0c2135acb046c9351a633c3b5b254a46 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-07 | 197 | 92 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.46e-07 | 148 | 92 | 6 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.46e-07 | 148 | 92 | 6 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.27e-07 | 151 | 92 | 6 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.27e-07 | 151 | 92 | 6 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.16e-07 | 154 | 92 | 6 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.16e-07 | 154 | 92 | 6 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.16e-07 | 154 | 92 | 6 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.16e-07 | 154 | 92 | 6 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.47e-07 | 155 | 92 | 6 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.47e-07 | 155 | 92 | 6 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-06 | 164 | 92 | 6 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l14|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-06 | 169 | 92 | 6 | 813472d429c0b12580b17b440e00a6d8beb7947f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 169 | 92 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.45e-06 | 170 | 92 | 6 | fefb07a7e308b620f946b9ff2b01e1796446fe38 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-06 | 175 | 92 | 6 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-06 | 175 | 92 | 6 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-06 | 175 | 92 | 6 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-06 | 175 | 92 | 6 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-06 | 178 | 92 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.90e-06 | 178 | 92 | 6 | 71ac2eca5cf13a91f86b80690748b0788392dcfc | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-06 | 184 | 92 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-06 | 184 | 92 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-06 | 184 | 92 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-06 | 187 | 92 | 6 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.68e-06 | 189 | 92 | 6 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.68e-06 | 189 | 92 | 6 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.94e-06 | 192 | 92 | 6 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-06 | 193 | 92 | 6 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.03e-06 | 193 | 92 | 6 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.03e-06 | 193 | 92 | 6 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-06 | 193 | 92 | 6 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-06 | 193 | 92 | 6 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.21e-06 | 195 | 92 | 6 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.40e-06 | 197 | 92 | 6 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.40e-06 | 197 | 92 | 6 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.40e-06 | 197 | 92 | 6 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.40e-06 | 197 | 92 | 6 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.40e-06 | 197 | 92 | 6 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.40e-06 | 197 | 92 | 6 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 3.51e-06 | 198 | 92 | 6 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.51e-06 | 198 | 92 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.51e-06 | 198 | 92 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 3.51e-06 | 198 | 92 | 6 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 3.61e-06 | 199 | 92 | 6 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.71e-06 | 200 | 92 | 6 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.71e-06 | 200 | 92 | 6 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.71e-06 | 200 | 92 | 6 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.71e-06 | 200 | 92 | 6 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.71e-06 | 200 | 92 | 6 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.71e-06 | 200 | 92 | 6 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-MyoFB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.27e-05 | 145 | 92 | 5 | ac41c6c02b7d78162b86222983688f54d04ac47d | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-05 | 157 | 92 | 5 | 0fecc14959c4c9efc19d5c06475a890e0a30f148 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 158 | 92 | 5 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 158 | 92 | 5 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.05e-05 | 160 | 92 | 5 | 5cd4fbbd2ce671a8377416eff94041a111375dee | |
| ToppCell | LPS-IL1RA-Epithelial_airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-05 | 161 | 92 | 5 | 472c354f5ee148b37a5dfb795e83348ecb1643f1 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 2.37e-05 | 165 | 92 | 5 | 9795ce31689bc63f5a2d68725ef00b23a90c3846 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.51e-05 | 167 | 92 | 5 | 063ec29b32e40aaa138a691da3a79ee8eef0c2be | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_cell|Distal / Age, Tissue, Lineage and Cell class | 2.66e-05 | 169 | 92 | 5 | 425d89ab69e9f9eb3df84056676423e390cc6ab1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.66e-05 | 169 | 92 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-8|TCGA-Liver / Sample_Type by Project: Shred V9 | 2.82e-05 | 171 | 92 | 5 | c4a919fe3d56ae6df2fcab6686abacc10befc053 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.98e-05 | 173 | 92 | 5 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_ciliated|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.06e-05 | 174 | 92 | 5 | b8d1c556290d188f56aeefc17f03119686945fe7 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.06e-05 | 174 | 92 | 5 | 00cf27bc23af1472a507be31fba6245a8fdd901b | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 3.23e-05 | 176 | 92 | 5 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.41e-05 | 178 | 92 | 5 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | Ciliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 3.60e-05 | 180 | 92 | 5 | bdea5ec6b60fc8c7cce4d71db5da74ac8675e211 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 180 | 92 | 5 | f6a2208960d0df1500c974cc44c3c054cd7475a9 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.69e-05 | 181 | 92 | 5 | beb2771820956be8b190c0088ae3c4efdb53c897 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 3.79e-05 | 182 | 92 | 5 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.89e-05 | 183 | 92 | 5 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.89e-05 | 183 | 92 | 5 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 184 | 92 | 5 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 184 | 92 | 5 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 184 | 92 | 5 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-05 | 185 | 92 | 5 | 70de48988c1f8e0809afc8092b663aa439d8e528 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.10e-05 | 185 | 92 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.10e-05 | 185 | 92 | 5 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.10e-05 | 185 | 92 | 5 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 4.10e-05 | 185 | 92 | 5 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-05 | 186 | 92 | 5 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.21e-05 | 186 | 92 | 5 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.21e-05 | 186 | 92 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.21e-05 | 186 | 92 | 5 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-05 | 186 | 92 | 5 | d6c8ce2a32c218dcc63d861cc247152430ed3c8c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-05 | 186 | 92 | 5 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-05 | 187 | 92 | 5 | 04dba2ed09ee4180830bdf0191921696697ea234 | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 4.31e-05 | 187 | 92 | 5 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.31e-05 | 187 | 92 | 5 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-05 | 187 | 92 | 5 | 805dafe22f835ece4dd091d8030d0a63b52a48dd | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 4.42e-05 | 188 | 92 | 5 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 4.42e-05 | 188 | 92 | 5 | 606907c865bd2f11bb6474932716550f7723d858 | |
| Drug | Zonisamide | 4.99e-07 | 17 | 89 | 4 | DB00909 | |
| Drug | APETx1, Anthopleura elegantissima | 1.15e-06 | 6 | 89 | 3 | ctd:C475726 | |
| Drug | potassium | SLC38A1 ATP8B3 PLA2R1 KLK6 MYL3 IMPA1 KCNF1 SYNE1 SCN2A SCN4A ATP2C2 SCN9A MLH1 PKN2 GRIN2C CNGB1 | 1.63e-06 | 1008 | 89 | 16 | CID000000813 |
| Drug | AC1L1IZE | 1.27e-05 | 131 | 89 | 6 | CID000004799 | |
| Drug | mu-conotoxin KIIIA, Conus kinoshitai | 1.51e-05 | 2 | 89 | 2 | ctd:C502265 | |
| Drug | Tetrodotoxin | 1.79e-05 | 40 | 89 | 4 | ctd:D013779 | |
| Drug | Biliton | 1.98e-05 | 41 | 89 | 4 | CID000002974 | |
| Drug | AC1L4Q08 | 2.54e-05 | 15 | 89 | 3 | CID000161747 | |
| Drug | IC261 | 3.76e-05 | 96 | 89 | 5 | CID000003674 | |
| Drug | 1,2-dicaprin | 4.04e-05 | 49 | 89 | 4 | CID000001321 | |
| Drug | Scorpion Venoms | 4.52e-05 | 18 | 89 | 3 | ctd:D012604 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 4.52e-05 | 3 | 89 | 2 | ctd:C561228 | |
| Drug | magnesium | DNAI1 KLK6 IMPA1 DNAH10 ATP2C2 ENTPD5 MLH1 DGKA DGKG DGKD RBKS PKN2 GRIN2C DNAH5 DNAH8 ABCB4 | 4.96e-05 | 1325 | 89 | 16 | CID000000888 |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 3.88e-11 | 10 | 83 | 5 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 3.88e-11 | 10 | 83 | 5 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.22e-10 | 12 | 83 | 5 | DOID:0060170 (implicated_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 4.10e-07 | 22 | 83 | 4 | DOID:2030 (implicated_via_orthology) | |
| Disease | Epilepsy | 6.63e-07 | 109 | 83 | 6 | C0014544 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.78e-06 | 9 | 83 | 3 | C3502809 | |
| Disease | Epilepsy, Cryptogenic | 3.59e-06 | 82 | 83 | 5 | C0086237 | |
| Disease | Awakening Epilepsy | 3.59e-06 | 82 | 83 | 5 | C0751111 | |
| Disease | Aura | 3.59e-06 | 82 | 83 | 5 | C0236018 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 6.01e-06 | 13 | 83 | 3 | C0751122 | |
| Disease | Neurodevelopmental Disorders | 6.67e-06 | 93 | 83 | 5 | C1535926 | |
| Disease | epilepsy (implicated_via_orthology) | 6.88e-06 | 163 | 83 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 7.82e-06 | 2 | 83 | 2 | C4551549 | |
| Disease | B Virus Infection | 2.34e-05 | 3 | 83 | 2 | C0037140 | |
| Disease | Benign familial infantile epilepsy | 2.34e-05 | 3 | 83 | 2 | cv:C5575231 | |
| Disease | Postherpetic neuralgia | 2.34e-05 | 3 | 83 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 2.34e-05 | 3 | 83 | 2 | C0019372 | |
| Disease | waist circumference | 2.85e-05 | 429 | 83 | 8 | EFO_0004342 | |
| Disease | NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial measurement | 4.67e-05 | 4 | 83 | 2 | EFO_0803292 | |
| Disease | Kartagener syndrome (is_implicated_in) | 4.67e-05 | 4 | 83 | 2 | DOID:0050144 (is_implicated_in) | |
| Disease | interleukin 5 measurement | 6.68e-05 | 28 | 83 | 3 | EFO_0008185 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 6.68e-05 | 28 | 83 | 3 | DOID:4194 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.13e-05 | 152 | 83 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Cerebellar Ataxia | 7.77e-05 | 5 | 83 | 2 | C0007758 | |
| Disease | Familial benign neonatal epilepsy | 1.16e-04 | 6 | 83 | 2 | C0220669 | |
| Disease | Colorectal Carcinoma | 1.59e-04 | 702 | 83 | 9 | C0009402 | |
| Disease | Seizure, Febrile, Simple | 1.63e-04 | 7 | 83 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 1.63e-04 | 7 | 83 | 2 | C0751057 | |
| Disease | Lewy body dementia (is_implicated_in) | 1.63e-04 | 7 | 83 | 2 | DOID:12217 (is_implicated_in) | |
| Disease | Early Childhood Epilepsy, Myoclonic | 2.16e-04 | 8 | 83 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 2.16e-04 | 8 | 83 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 2.16e-04 | 8 | 83 | 2 | C0338479 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 2.16e-04 | 8 | 83 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 2.16e-04 | 8 | 83 | 2 | C0438414 | |
| Disease | Myoclonic Absence Epilepsy | 2.16e-04 | 8 | 83 | 2 | C0393703 | |
| Disease | Ciliopathies | 2.68e-04 | 110 | 83 | 4 | C4277690 | |
| Disease | Febrile Convulsions | 2.78e-04 | 9 | 83 | 2 | C0009952 | |
| Disease | Atypical hemolytic-uremic syndrome | 2.78e-04 | 9 | 83 | 2 | cv:C2931788 | |
| Disease | Hemolytic-uremic syndrome | 2.78e-04 | 9 | 83 | 2 | cv:C0019061 | |
| Disease | Myoclonic Epilepsy | 2.78e-04 | 9 | 83 | 2 | C0014550 | |
| Disease | Drug habituation | 3.17e-04 | 115 | 83 | 4 | C0013170 | |
| Disease | Drug abuse | 3.17e-04 | 115 | 83 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 3.17e-04 | 115 | 83 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 3.17e-04 | 115 | 83 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 3.17e-04 | 115 | 83 | 4 | C0013222 | |
| Disease | Drug Dependence | 3.17e-04 | 115 | 83 | 4 | C1510472 | |
| Disease | Substance Dependence | 3.17e-04 | 115 | 83 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 3.17e-04 | 115 | 83 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.17e-04 | 115 | 83 | 4 | C0029231 | |
| Disease | Substance abuse problem | 3.28e-04 | 116 | 83 | 4 | C0740858 | |
| Disease | Epilepsy, Myoclonic, Infantile | 3.47e-04 | 10 | 83 | 2 | C0917800 | |
| Disease | Bipolar Disorder | 3.98e-04 | 477 | 83 | 7 | C0005586 | |
| Disease | visceral adipose tissue measurement | 4.18e-04 | 481 | 83 | 7 | EFO_0004765 | |
| Disease | Myoclonic Astatic Epilepsy | 4.23e-04 | 11 | 83 | 2 | C0393702 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 6.96e-04 | 14 | 83 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | rosacea severity measurement | 8.01e-04 | 147 | 83 | 4 | EFO_0009180 | |
| Disease | MMR-related febrile seizures | 8.02e-04 | 15 | 83 | 2 | EFO_0006519 | |
| Disease | thyroid volume | 9.14e-04 | 16 | 83 | 2 | EFO_0004865 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 9.14e-04 | 16 | 83 | 2 | C0393706 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 1.16e-03 | 18 | 83 | 2 | HP_0002373 | |
| Disease | facial asymmetry measurement | 1.30e-03 | 19 | 83 | 2 | EFO_0009751 | |
| Disease | complement factor H-related protein 3 measurement | 1.34e-03 | 169 | 83 | 4 | EFO_0600056 | |
| Disease | Lung diseases | 1.40e-03 | 78 | 83 | 3 | C0024115 | |
| Disease | Intellectual Disability | 1.65e-03 | 447 | 83 | 6 | C3714756 | |
| Disease | Bronchiectasis | 1.74e-03 | 22 | 83 | 2 | C0006267 | |
| Disease | West Syndrome | 2.07e-03 | 24 | 83 | 2 | C0037769 | |
| Disease | birth weight, parental genotype effect measurement | 2.14e-03 | 192 | 83 | 4 | EFO_0004344, EFO_0005939 | |
| Disease | cognitive function measurement | SLC38A1 NRXN3 SCN2A CNGB3 MTMR2 FBXL17 PLEKHA1 DNAH5 SH3RF3 SRSF9 PURG | 2.23e-03 | 1434 | 83 | 11 | EFO_0008354 |
| Disease | diet measurement | 2.74e-03 | 1049 | 83 | 9 | EFO_0008111 | |
| Disease | body weight | SLC38A1 CRELD1 IGF1R NRXN3 FBXL17 DGKG PLEKHA1 DMD CPSF2 PURG | 2.81e-03 | 1261 | 83 | 10 | EFO_0004338 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YGDVEMKNGVCRKES | 401 | O95696 | |
| GLYKDEGLMIQCDKC | 2591 | Q9NR48 | |
| DHMKLKVQGVECLYG | 136 | Q9Y6Y1 | |
| ECCRAFGGKDIKVYM | 576 | Q9P2I0 | |
| QLCTAMEQYKGDKDV | 476 | Q8NEN0 | |
| CVGQKYEKIFEMLEG | 136 | P0DMU8 | |
| VIYAGFDTKIMKNCG | 351 | O60423 | |
| MFLVGTEEGKIYKCS | 511 | Q9UI46 | |
| MCQQVYARKEALKGG | 1141 | P11532 | |
| LFEEGYTNKGMKIAC | 436 | O60231 | |
| CVGQKYEKIFEMLEG | 136 | P0DMV0 | |
| MNAVEEGKGIFYNIK | 716 | O75185 | |
| VRKYMQKEGCAGEVV | 226 | Q68EN5 | |
| AELMQQFDVIYGKCG | 181 | Q86VD1 | |
| MVCKVGKDSFGNDYI | 71 | Q9H477 | |
| MERGKIGLDFCKYLV | 331 | O00571 | |
| ICAEGYKQMEGICVK | 331 | Q96HD1 | |
| KQDKICLMAGGYEVI | 191 | Q58FF3 | |
| GVSALQIYCMKEGVK | 611 | Q96AA8 | |
| SDMEQFCKIKGYLEE | 686 | Q96AA8 | |
| MIDYEKGGILKVEDF | 341 | O75356 | |
| KCEMKITYGQCGDVL | 66 | P08590 | |
| CLGRKYEKIFEMLEG | 136 | P0DMU9 | |
| IAKLMGEGYAFEEVK | 936 | Q13191 | |
| GMVYEGVAKGVVKDE | 1011 | P08069 | |
| MDKYDVIKAIGQGAF | 1 | Q6P3R8 | |
| CVGQKYEKIFEMLEG | 136 | Q8NHU0 | |
| TKDMGRCLGKYVVVF | 1856 | Q96JB1 | |
| FMGCLKEVVYKNNDI | 401 | Q9Y4C0 | |
| LKLFEDGEMAKYVQG | 31 | P23743 | |
| GQKELYLEACKLMGV | 81 | Q0VAA2 | |
| GENIKDMAKDVTYIC | 81 | Q13614 | |
| QAFKGVGCLYEKESM | 571 | Q76FK4 | |
| YGKEKMYECKVCGET | 621 | Q9GZU2 | |
| CYGRGNVTMDEIKKA | 491 | P21439 | |
| CYIELQENEVMKEGG | 771 | Q460N5 | |
| DGCVSAKGELVMQYK | 411 | P49619 | |
| EIKECADEPVGKGYM | 186 | Q92896 | |
| CVGQKYEKIFEMLEG | 136 | Q5HYN5 | |
| CVGQKYEKIFEMLEG | 136 | P0DMV2 | |
| YAKTGDTIEFMCKLG | 291 | Q02985 | |
| EEMALGICAKGVIVY | 561 | Q68DX3 | |
| FGQCYKISDEGMIVI | 471 | Q9UF56 | |
| CVGQKYEKIFEMLEG | 136 | Q5DJT8 | |
| KTGDTIEFMCKLGYN | 541 | Q92496 | |
| CVGQKYEKIFEMLEG | 136 | P0DMV1 | |
| GFKMEVGQYIFVKCP | 316 | P04839 | |
| KCVMNNYFGIGLDAK | 761 | Q16760 | |
| GMLKFVEAVMGYCDV | 3236 | Q8IVF4 | |
| CVGQKYEKIFEMLEG | 136 | P0DMU7 | |
| KDMGRCLGKYVVVFN | 1991 | Q8TE73 | |
| TECKMNEGIVKLYNE | 2241 | Q3ZCN5 | |
| MDPVVCVEVGDDKKY | 271 | Q9HC10 | |
| GENFIKYEEEMRKIC | 311 | Q9UJV8 | |
| EMSGIKVGDDKCYLV | 436 | Q9H1H9 | |
| LYKVMEAGDFICKAV | 341 | Q8TB92 | |
| VVMECGLDVKYFKPG | 126 | Q8WWV3 | |
| AGEIYVMVNDKPVCK | 336 | Q9UGI8 | |
| DVCYADVQKDGVGMV | 136 | Q13242 | |
| VVGMQLFGKSYKECV | 716 | P35499 | |
| KMLSNFGDCVQYKEI | 1226 | Q8NF91 | |
| CDYVFVNGKEMKGKV | 486 | Q14C87 | |
| KIEFGVVYSCVEGKM | 116 | P29218 | |
| AVVGMQLFGKSYKEC | 881 | Q15858 | |
| ENFLRDMCKKYGEVE | 116 | Q9UPS6 | |
| CLEMDIKAQGYKVFS | 216 | Q9BQ13 | |
| VYDECKEGVAKMDQI | 731 | Q96JS3 | |
| VKIADFGLCKEGMGY | 796 | Q16513 | |
| IGCEDKTLAFKMNGY | 231 | P40692 | |
| DCGKEGYGFVCEKMQ | 1086 | Q13018 | |
| VVGMQLFGKSYKDCV | 906 | P35498 | |
| VKLMEYCQHGVKEGA | 756 | O75891 | |
| NDYVCKKGEIGREMY | 986 | Q14028 | |
| KVDLFKGCDTQMIYD | 521 | Q9NQW8 | |
| MEELGECAFGKIYKG | 476 | Q01973 | |
| MFEIKKICCIGAGYV | 1 | O60701 | |
| VCLSGFLDEVMKKYG | 501 | Q96HI0 | |
| CNYKLLKTGIENGDM | 711 | Q8N3U4 | |
| HKGEMYRVLEKCQDG | 486 | Q8TEJ3 | |
| CGGYTLKVLMENKFL | 661 | P23497 | |
| AVVGMQLFGKSYKEC | 896 | Q99250 | |
| VVGMQLFGKSYKECV | 891 | Q9UQD0 | |
| GIMFVIDSGYCKLKV | 816 | Q92620 | |
| VKEIKPGEDMICQLY | 191 | Q8N841 | |
| GDEKVCMDVFKKYIN | 1121 | Q8N9V7 | |
| NLILRGGMKFYECKE | 141 | Q6ZSS3 | |
| KTYVGFDMGICKTEN | 616 | Q86YA3 | |
| AVIKAGYCVKQGAVM | 191 | Q9HB21 | |
| EEEVNYLFNGVKKMG | 676 | Q8NA31 | |
| SKETGCMVYEKLGEQ | 126 | Q9H2H9 | |
| DKTKQREMVYCLEQG | 781 | P49815 | |
| ITQNMLCAGDEKYGK | 176 | Q92876 | |
| EVYYFGEVHMKKGIC | 91 | Q9H3M0 | |
| NLVKKAIYAMVEGDC | 301 | Q147X3 | |
| AVLNYMAGKDEGCKL | 731 | Q14957 |